SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

BIOVIE INC.
Date: May 20, 2025 · CIK: 0001580149 · Accession: 0000000000-25-005378

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
May 20, 2025
Author
Division of
Form
UPLOAD
Company
BIOVIE INC.

Letter

Re: BioVie Inc. Draft Registration Statement on Form S-1 Submitted May 15, 2025 CIK No. 0001580149 Dear Cuong Do:

May 20, 2025

Cuong Do Chief Executive Officer BioVie Inc. 680 W Nye Lane Suite 201 Carson City, NV 89703

This is to advise you that we do not intend to review your registration statement.

We request that you publicly file your registration statement at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Jessica Dickerson at 202-551-8013 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Stephen E. Older, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 May 20, 2025

Cuong Do
Chief Executive Officer
BioVie Inc.
680 W Nye Lane Suite 201
Carson City, NV 89703

 Re: BioVie Inc.
 Draft Registration Statement on Form S-1
 Submitted May 15, 2025
 CIK No. 0001580149
Dear Cuong Do:

 This is to advise you that we do not intend to review your registration
statement.

 We request that you publicly file your registration statement at least
two business
days prior to the requested effective date and time. Please refer to Rules 460
and 461
regarding requests for acceleration. We remind you that the company and its
management are
responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review,
comments, action or absence of action by the staff.

 Please contact Jessica Dickerson at 202-551-8013 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Stephen E. Older, Esq.
</TEXT>
</DOCUMENT>